Cancer cells can override growth signals, ignoring cues to stop growing.
They resist signals that would typically lead to cell death.
New cancer cells can grow blood vessels to aid in spreading.
Cancer cells possess an infinite lifespan, allowing for relentless proliferation.
Cancer cells do not die when they should, leading to additional accumulation of genetic damage in pre-cancerous cells.
This disruption results in a loss of homeostatic balance within normal tissues, affecting structure and function.
Pre-cancerous cells may acquire genetic alterations that enable them to evade cell death.
These cells can persist and accumulate further mutations, aiding in the development of additional hallmark traits of cancer.
The progression from pre-cancerous to cancerous states is crucial in the multistep development of cancer.
Cell death is essential for adult tissue homeostasis and eliminating old or damaged cells, thus maintaining tissue structure and function.
It allows for the replacement of senescent or potentially harmful cells with new ones.
Also known as apoptosis, PCD is a controlled method of cell death that serves physiological functions.
Insufficient apoptosis during embryonic development can lead to malformations, such as webbed or fused digits.
Not all forms of cell death are apoptotic; other mechanisms exist.
Apoptosis is a well-regulated process, while necrosis often results from acute injury and triggers inflammation.
Apoptosis: cells die neatly without causing local damage and are phagocytosed without an inflammatory response.
Necrosis: Cells swell and burst, leading to tissue damage and an inflammatory response.
Compact cells; shrinkage and nuclear condensation.
Membrane blebbing and fragmentation into apoptotic bodies.
DNA disintegration into smaller fragments, leading to DNA 'laddering'.
Plasma membrane alterations – externalization of phosphatidyl-serine (PS) serves as an "eat me" signal.
Gradual compromise of plasma membrane integrity, allowing larger molecules to enter.
Not all cell death is classified as apoptosis. Other regulated forms of cell death include:
Necroptosis, pyroptosis, and ferroptosis.
Autophagy can promote either cell survival or death depending on context.
Apoptosis involves two pathways:
Extrinsic Pathway: Triggered by death ligands binding to receptors, leading to caspase activation.
Intrinsic Pathway: Triggered by intracellular signals, often involving cytochrome c release from mitochondria.
Caspases are proteases that play a central role in apoptosis by cleaving specific substrates, leading to morphological changes.
They are activated by proteolytic cleavage or dimerization, initiating a cascade that amplifies the apoptotic signal.
Cancer cells evade apoptosis by altering components of apoptotic signaling pathways, including:
Decreased expression of pro-apoptotic proteins (e.g., Bax) and increased expression of anti-apoptotic factors (e.g., Bcl-2).
Mutational inactivation of p53, impacting intrinsic apoptotic pathways.
p53 acts as the guardian of the genome by coordinating responses to cellular stress and activating apoptosis.
Mutations in p53 are common in cancers and critically impair apoptotic responses.
Members of the Bcl-2 family regulate mitochondria-mediated apoptosis through their balance of pro- and anti-apoptotic signals.
Anti-apoptotic members (e.g., Bcl-2, Bcl-xL) inhibit pro-apoptotic members (e.g., Bak, Bax), which mediate mitochondrial membrane permeabilization (MOMP) and cytochrome c release.
Cancer cells may employ various strategies to evade apoptosis, including:
Overexpression of anti-apoptotic factors like Bcl-2.
Inactivation of pro-apoptotic pathways, such as p53 and Bax.
Blocking apoptosome formation by loss of essential proteins like APAF-1.
Regular retrieval practice and self-assessment are vital for reinforcing knowledge on the mechanisms of apoptosis and its significance in cancer biology.